Role of microsatellite instability in the management of colorectal cancers

被引:58
作者
Buecher, Bruno [1 ]
Cacheux, Wulfran [1 ]
Rouleau, Etienne [2 ]
Dieumegard, Barbara [3 ]
Mitry, Emmanuel [3 ,4 ]
Lievre, Astrid [3 ,4 ]
机构
[1] Grp Hosp, Inst Curie, Dept Med Oncol, F-75248 Paris 5, France
[2] Rene Huguenin Hosp, Dept Oncogenet, Inst Curie, Grp Hosp, F-92210 St Cloud, France
[3] Rene Huguenin Hosp, Dept Med Oncol, Inst Curie, Grp Hosp, F-92210 St Cloud, France
[4] Univ Versailles St Quentin Yvelines, Fac Hlth Sci, Versailles, France
关键词
Colorectal cancer; Lynch syndrome; Microsatellite instability; Prognosis; III COLON-CANCER; DNA MISMATCH REPAIR; DISEASE-FREE SURVIVAL; LYNCH-SYNDROME; ADJUVANT CHEMOTHERAPY; STAGE-II; MONONUCLEOTIDE REPEATS; FLUOROURACIL; LEUCOVORIN; IRINOTECAN;
D O I
10.1016/j.dld.2012.10.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Microsatellite instability is the consequence of a deficient mismatch repair system. It has a key role in the diagnostic strategy of Lynch syndrome, where tumours are all characterized by the presence of this phenotype. Microsatellite instability is therefore essential in the selection of colorectal cancer patients in whom a germline analysis of Mismatch Repair genes is possibly indicated. Moreover, microsatellite instability tumours are associated with a good prognosis and a resistance to fluorouracil-based adjuvant chemotherapy, which has a clinical application mainly in stage II colon cancer patients in whom adjuvant chemotherapy has a less beneficial effect than in stage III and outcome in presence of microsatellite instability is excellent. Recent data suggest that impact of microsatellite instability on benefit to fluorouracil-based adjuvant chemotherapy is dependent of the molecular mechanism involved in this genetic instability since an improved survival has been reported with adjuvant fluorouracil in microsatellite instability colorectal cancers of germline origin but not in sporadic cases. Predictive value of microsatellite instability on response to fluorouracil/oxaliplatin adjuvant chemotherapy has been less evaluated but recent studies suggest that the favorable outcome of Microsatellite instability tumours is maintained in patients receiving FOLFOX. (c) 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:441 / 449
页数:9
相关论文
共 78 条
  • [1] A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors
    Agostini, Marco
    Enzo, Maria Vittoria
    Morandi, Luca
    Bedin, Chiara
    Pizzini, Silvia
    Mason, Silvia
    Bertorelle, Roberta
    Urso, Emanuele
    Mescoli, Claudia
    Lise, Mario
    Pucciarelli, Salvatore
    Nitti, Donato
    [J]. CANCER BIOMARKERS, 2010, 6 (01) : 49 - 61
  • [2] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
    Andre, T
    Boni, C
    Mounedji-Boudiaf, L
    Navarro, M
    Tabernero, J
    Hickish, T
    Topham, C
    Zaninelli, M
    Clingan, P
    Bridgewater, J
    Tabah-Fisch, I
    de Gramont, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2343 - 2351
  • [3] Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
    Bertagnolli, Monica M.
    Niedzwiecki, Donna
    Compton, Carolyn C.
    Hahn, Hejin P.
    Hall, Margaret
    Damas, Beatrice
    Jewell, Scott D.
    Mayer, Robert J.
    Goldberg, Richard M.
    Saltz, Leonard B.
    Warren, Robert S.
    Redston, Mark
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) : 1814 - 1821
  • [4] Boland CR, 1998, CANCER RES, V58, P5248
  • [5] Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
    Bonadona, Valerie
    Bonaiti, Bernard
    Olschwang, Sylviane
    Grandjouan, Sophie
    Huiart, Laetitia
    Longy, Michel
    Guimbaud, Rosine
    Buecher, Bruno
    Bignon, Yves-Jean
    Caron, Olivier
    Colas, Chrystelle
    Nogues, Catherine
    Lejeune-Dumoulin, Sophie
    Olivier-Faivre, Laurence
    Polycarpe-Osaer, Florence
    Nguyen, Tan Dat
    Desseigne, Francoise
    Saurin, Jean-Christophe
    Berthet, Pascaline
    Leroux, Dominique
    Duffour, Jacqueline
    Manouvrier, Sylvie
    Frebourg, Thierry
    Sobol, Hagay
    Lasset, Christine
    Bonaiti-Pellie, Catherine
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2304 - 2310
  • [6] Simplified identification of Lynch syndrome: A prospective, multicenter study
    Bonnet, Delphine
    Selves, Janick
    Toulas, Christine
    Danjoux, Marie
    Duffas, Jean Pierre
    Portier, Guillaume
    Kirzin, Sylvain
    Ghouti, Laurent
    Carrere, Nicolas
    Suc, Bertrand
    Alric, Laurent
    Barange, Karl
    Buscail, Louis
    Chaubard, Thierry
    Imani, Kamran
    Guimbaud, Rosine
    [J]. DIGESTIVE AND LIVER DISEASE, 2012, 44 (06) : 515 - 522
  • [7] Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis
    Buhard, O
    Suraweera, N
    Lectard, A
    Duval, A
    Hamelin, R
    [J]. DISEASE MARKERS, 2004, 20 (4-5) : 251 - 257
  • [8] Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
    Carethers, JM
    Smith, EJ
    Behling, CA
    Nguyen, L
    Tajima, A
    Doctolero, RT
    Cabrera, BL
    Goel, M
    Arnold, CA
    Miyai, K
    Boland, CR
    [J]. GASTROENTEROLOGY, 2004, 126 (02) : 394 - 401
  • [9] Choi SW, 2002, CLIN CANCER RES, V8, P2311
  • [10] BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer
    Deng, GR
    Bell, I
    Crawley, S
    Gum, J
    Terdiman, JP
    Allen, BA
    Truta, B
    Sleisenger, MH
    Kim, YS
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (01) : 191 - 195